What does stable disease mean on my Non-Small Cell Lung Cancer scan results

Understanding "Stable Disease" on Your NSCLC Scan Results

Great question—this is an important term to understand when tracking your cancer treatment response.

What "Stable Disease" Means

Stable disease means your cancer is not growing and not shrinking. On your imaging scans (CT, PET-CT, or other imaging), the tumors appear essentially the same size and in the same locations as they were on your previous scan. There are no new tumors, and the existing ones haven't gotten larger.

Think of it this way: if your tumor was 3 cm on your last scan, it's still approximately 3 cm now—not bigger, not smaller.

Why This Matters for NSCLC Treatment

According to the NCCN Guidelines for Non-Small Cell Lung Cancer, stable disease is actually a positive response to treatment. When doctors evaluate how well your cancer is responding to therapy, they look for three main outcomes:

1. Response (tumor shrinking) — best outcome
2. Stable disease (tumor unchanged) — good outcome
3. Progression (tumor growing) — indicates treatment may need to change

The NCCN Guidelines note that patients receiving systemic therapy (chemotherapy, targeted therapy, or immunotherapy) who achieve stable disease typically continue on their current treatment plan, as it's working to control the cancer.

What Happens Next

If your scans show stable disease, your oncology team will typically:

• Continue your current treatment for additional cycles (usually 4-6 total cycles of chemotherapy, or ongoing targeted/immunotherapy depending on your specific treatment)
• Repeat imaging after every 2-3 cycles to monitor for continued stability or response
• Assess your overall tolerance to treatment and manage any side effects

Important Questions to Ask Your Doctor

Since you have stable disease, these questions can help you understand your specific situation:

1. "How many more treatment cycles do you recommend, and why?" — Your doctor will have a specific plan based on your cancer type and stage.

2. "When will we do the next scan to check my progress?" — This helps you understand the monitoring schedule.

3. "What would indicate we need to change treatment?" — Understanding the warning signs helps you know what symptoms or findings would prompt a treatment change.

4. "Are there any biomarkers or genetic tests on my tumor that might affect my treatment options?" — This is especially relevant for NSCLC, where specific mutations (like EGFR, ALK, or PD-L1 status) can guide treatment decisions.

5. "What is my overall prognosis with stable disease on this treatment?" — Your doctor can discuss your individual outlook based on your complete clinical picture.

The Bottom Line

Stable disease is not bad news—it means your treatment is working to control the cancer. Your tumor isn't progressing, which is the goal of cancer treatment. Many patients achieve stable disease and maintain it for extended periods, which can mean months or years of good quality of life while on treatment.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Sources: NCCN Guidelines for Non-Small Cell Lung Cancer, Version 8.2025